Over 100% Increase From Last Year, Meet CEO At Benzinga Cannabis Capital Conference
[ad_1] Avicanna AVCNF, a biopharmaceutical company focused on cannabinoid-based products, released its Q2 2022 highlights: 6-month revenue of $2.14 million, representing 101% increase from the same period in the prior year, supported by…